ArthroCare prices flotation at upper end of expectations
This article was originally published in Clinica
Executive Summary
ArthroCare has priced its initial public offering at $14 a share, at the upper end of the range assumed in the prospectus. The Californian development-stage company intends to use the $28 million raised from the sale of 2.2 million shares to expand the manufacturing and marketing of its arthroscopic surgical equipment for knee, shoulder, elbow and ankle procedures.